Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
about
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situHeparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.Hepatic stellate cells: central modulators of hepatic carcinogenesis.Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours.MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.Treating advanced hepatocellular carcinoma: How to get out of first gear.Abl interconnects oncogenic Met and p53 core pathways in cancer cells.The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches.Advanced Hepatocellular Cancer: the Current State of Future Research.HGF/c-Met signalling promotes Notch3 activation and human vascular smooth muscle cell osteogenic differentiation in vitro.Dissecting the role of human embryonic stem cell-derived mesenchymal cells in human umbilical vein endothelial cell network stabilization in three-dimensional environmentsHepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.
P2860
Q21195234-31B0FD1B-0194-4A8B-B2FE-1091FF0A4B75Q34388854-B0DA6557-8985-41E6-B86B-4D703CD3A38DQ35642468-6EAB2E2E-917E-4215-8E7E-1E005F26F4EBQ37158509-D77647CE-BE17-468F-9893-E3C6FD1DD5A5Q37745389-2D248028-9090-4AAF-8CB0-662EEE3DA0C3Q38217737-8252DF5D-40B0-416C-818C-73A605435020Q38392007-7B9E9C78-BC1C-42AA-9141-DA0578D1567EQ38674137-5E80123A-0A0B-47E3-9050-495BA4BD8302Q38848537-174B1A3A-4078-47DB-A46A-03344161C094Q41958391-7CF95881-BCA8-4CCE-BA49-3A23A64AD44FQ42429806-387B5C94-BEAD-4100-B944-7969FCAA3675Q50977853-4A45AE64-30EC-4620-B238-DB654132A652
P2860
Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inhibition of angiogenesis and ...... tor-mediated NK4 gene therapy.
@en
Inhibition of angiogenesis and ...... tor-mediated NK4 gene therapy.
@nl
type
label
Inhibition of angiogenesis and ...... tor-mediated NK4 gene therapy.
@en
Inhibition of angiogenesis and ...... tor-mediated NK4 gene therapy.
@nl
prefLabel
Inhibition of angiogenesis and ...... tor-mediated NK4 gene therapy.
@en
Inhibition of angiogenesis and ...... tor-mediated NK4 gene therapy.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of angiogenesis and ...... tor-mediated NK4 gene therapy.
@en
P2093
Chris J L M Meijer
Daniëlle A M Heideman
G Johan A Offerhaus
Mikael E Craanen
Peter J F Snijders
Renée M Overmeer
Theodorus B M Hakvoort
Victor W van Beusechem
Winald R Gerritsen
Wouter H Lamers
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700856
P577
2005-12-01T00:00:00Z
P5875
P6179
1003831508